KURAONCOLOGY.COM: Keyword Density Checker

Total words: 2101 | 2-word phrases: 543 | 3-word phrases: 594 | 4-word phrases: 622

PAGE INFO

Title	Try to keep the title under 60 characters (78 characters) Kura Oncology \| The promise of precision oncology brought to life for patients
Description	Try to keep the meta description between 50 - 160 characters (116 characters) Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (28 characters) brought to life for patients

#	Keyword	Frequency	Density
1	clinical trials	9	1.66%
2	david anderson	7	1.29%
3	read more	6	1.10%
4	oncology in	6	1.10%
5	on oncology	5	0.92%
6	neck cancer?	5	0.92%
7	wpcontentuploadskuralogosvg david	5	0.92%
8	currents read	5	0.92%
9	– aml	5	0.92%
10	anderson wpcontentuploadskuralogosvg	5	0.92%
11	neck cancer	5	0.92%
12	kura oncology	4	0.74%
13	patients with	4	0.74%
14	oncology inc	4	0.74%
15	of clinical	4	0.74%
16	precision oncology	4	0.74%
17	of the	3	0.55%
18	the promise	3	0.55%
19	promise of	3	0.55%
20	cancer drugs	3	0.55%

#	Keyword	Frequency	Density
1	currents read more	5	0.84%
2	anderson wpcontentuploadskuralogosvg david	5	0.84%
3	david anderson wpcontentuploadskuralogosvg	4	0.67%
4	kura oncology inc	4	0.67%
5	the promise of	3	0.51%
6	liquid biopsies guide	3	0.51%
7	about us our	3	0.51%
8	biopsies guide the	3	0.51%
9	in patients with	3	0.51%
10	and neck cancer	3	0.51%
11	head and neck	3	0.51%
12	and neck cancer?	3	0.51%
13	of precision oncology	3	0.51%
14	dawn of precision	2	0.34%
15	the dawn of	2	0.34%
16	this the dawn	2	0.34%
17	of clinical oncology	2	0.34%
18	clinical oncology is	2	0.34%
19	journal of clinical	2	0.34%
20	2560 david anderson	2	0.34%
21	what pharma can	2	0.34%
22	pharma can teach	2	0.34%
23	with hras mutations	2	0.34%
24	precision oncology in	2	0.34%
25	precision oncology brought	2	0.34%
26	to life for	2	0.34%
27	brought to life	2	0.34%
28	oncology brought to	2	0.34%
29	metastatic hnscc with	2	0.34%
30	benefits open positions	2	0.34%

#	Keyword	Frequency	Density
1	david anderson wpcontentuploadskuralogosvg david	4	0.64%
2	head and neck cancer	3	0.48%
3	head and neck cancer?	3	0.48%
4	liquid biopsies guide the	3	0.48%
5	tipifarnib demonstrates encouraging efficacy	2	0.32%
6	fit001 – solid tumors	2	0.32%
7	trials fit001 – solid	2	0.32%
8	– hnscc ko2806 clinical	2	0.32%
9	kurrenthn – hnscc ko2806	2	0.32%
10	2021in currents read more	2	0.32%
11	aml tipifarnib clinical trials	2	0.32%
12	of precision oncology in	2	0.32%
13	– aml tipifarnib clinical	2	0.32%
14	companies say they’re ready	2	0.32%
15	but companies say they’re	2	0.32%
16	komet007 – aml komet008	2	0.32%
17	aml komet007 – aml	2	0.32%
18	investors but companies say	2	0.32%
19	dosing spooks investors but	2	0.32%
20	clinical trials komet001 –	2	0.32%
21	ziftomenib clinical trials komet001	2	0.32%
22	headneck cancer investors overview	2	0.32%
23	recurrent andor metastatic hnscc	2	0.32%
24	fda’s renewed focus on	2	0.32%
25	values life at kura	2	0.32%
26	2560 david anderson wpcontentuploadskuralogosvg	2	0.32%
27	hnscc with hras mutations	2	0.32%
28	metastatic hnscc with hras	2	0.32%
29	benefits open positions newsmedia	2	0.32%
30	precision oncology brought to	2	0.32%
31	journal of clinical oncology	2	0.32%
32	of clinical oncology is	2	0.32%
33	careers values life at	2	0.32%
34	dawn of precision oncology	2	0.32%
35	contact careers values life	2	0.32%
36	oncology brought to life	2	0.32%
37	brought to life for	2	0.32%
38	andor metastatic hnscc with	2	0.32%
39	information analyst coverage faqs	2	0.32%
40	this the dawn of	2	0.32%

#	URL	Whois	Check
1	https://www.youtube.com/watch?v=nN2FWLY00-c	Whois	youtube.com
2	https://www.pharmavoice.com/news/pharma-biotech-life-cycle-drug-Kura/650566/	Whois	pharmavoice.com
3	https://www.genengnews.com/topics/cancer/liquid-biopsies-guide-the-development-of-cancer-drugs/	Whois	genengnews.com
4	https://www.genengnews.com/topics/cancer/liquid-biopsies-guide-the-development-of-cancer-drugs/	Whois	genengnews.com
5	https://www.genengnews.com/topics/cancer/liquid-biopsies-guide-the-development-of-cancer-drugs/	Whois	genengnews.com
6	https://www.fiercebiotech.com/biotech/fda-s-renewed-focus-oncology-dosing-spooks-investors-but-companies-say-they-were-ready	Whois	fiercebiotech.com
7	https://www.esmo.org/oncology-news/tipifarnib-demonstrates-encouraging-efficacy-in-patients-with-recurrent-and-or-metastatic-hnscc-with-hras-mutations?hit=mail-snews	Whois	esmo.org
8	https://ascopubs.org/doi/full/10.1200/JCO.21.00569	Whois	ascopubs.org